Original Article
Effect of rosuvastatin on serum levels of vaspin and visfatin in patients with CAD
Author(s): Rehab Werida*, Lamiaa Khedr, Alaa El-Din El-Sisi and Mai Salama
AIM OF THE STUDY: Investigate the effect of Rosuvastatin on serum level of Vaspin and Visfatin in patients with CAD and determine the association between those adipokines and the severity of CAD.
BACKGROUND: Statin treatment is considered one of the most effective strategies for the stabilization of atherosclerotic plaques and is related with enhancements in result in patients with coronary course diseases (CAD). Vaspin and Visfatin are adipokines involved in atherosclerosis progression. Objective: assess the impact of Rosuvastatin on serum level of Vaspin and Visfatin in patients with CAD and the relationship of those adipokines with seriousness of CAD.
SETTING: Cardiology department, Tanta University Hospital, Egypt. METHODS: 80 pa.. Read More»
DOI:
10.4172/2368-0512.1000107
